Article Detail - JE Part A
Reminder: Proper Use of JW and JZ Modifiers for Drug Billing
Accurate billing for drugs and biologicals requires careful attention to CMS guidelines, particularly when addressing unused or discarded amounts from single-use vials or packages. The use of the JW and JZ modifiers plays a critical role in ensuring compliance and proper reimbursement.
CMS requires providers to accurately report the administration and any discarded portions of drugs or biologicals from single-dose containers. When billing:
- Providers must report any unused portion that is appropriately discarded, or
- Indicate there was zero amount discarded
In addition, billed units must align with the smallest dosage available from the manufacturer that can appropriately meet the patient's needs while minimizing wastage. This expectation reinforces the importance of both precision and compliance in drug billing practices.
Modifier JW is used to report the amount of drug that is discarded and not administered to any patient.
Use JW:
- Measurable amount of drug remaining in single-use vial or package
- Unused portion properly discarded and not used for another patient
In these cases:
- Administered amount and discarded amount are typically billed on separate claim lines
- JW modifier is appended to the line that reflects the discarded portion
Correct use of the JW modifier ensures transparency in billing and allows for appropriate reimbursement of drug wastage when applicable.
Modifier JZ is used to indicate that no amount of drug was discarded or not administered to any patient.
Use JZ:
- Entire dose from a single-use vial or package is administered, or
- No billable discarded amount
CMS requires the JZ modifier in scenarios where no wastage is present to clearly attest that zero drug wastage occurred.
This requirement ensures complete reporting, even when wastage is not applicable.